{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:31:21Z","timestamp":1747153881451,"version":"3.40.5"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11657-020-00830-4","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T18:03:21Z","timestamp":1602266601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinician\u2019s guide for the management and research of osteoporosis in North African men: a guidelines comparison, a cost-effectiveness analysis, and a local algorithm"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7700-6692","authenticated-orcid":false,"given":"Ahmed S.","family":"Mettawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed S.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohy E.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"issue":"6","key":"830_CR1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","volume":"285","author":"NIH Consensus Development Panel on Osteoporosis Prevention Diagnosis and Therapy","year":"2001","unstructured":"NIH Consensus Development Panel on Osteoporosis Prevention Diagnosis and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285(6):785\u2013795","journal-title":"JAMA"},{"issue":"1","key":"830_CR2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11657-017-0324-5","volume":"12","author":"J Compston","year":"2017","unstructured":"Compston J, Cooper A, Cooper C et al (2017) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 12(1):43\u201366","journal-title":"Arch Osteoporos"},{"issue":"Supplement 4","key":"830_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161435.GL","volume":"22","author":"PM Camacho","year":"2016","unstructured":"Camacho PM, Petak SM, Binkley N et al (2016) American association of clinical endocrinologists and american college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis \u2014 2016. Endocr Pract 22(Supplement 4):1\u201342","journal-title":"Endocr Pract"},{"issue":"10","key":"830_CR4","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R, National Osteoporosis Foundation (2014) Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359\u20132381","journal-title":"Osteoporos Int"},{"key":"830_CR5","unstructured":"Adib MG, Nauroy L, Fuleihan GE (2011) The Middle East & Africa regional audit: epidemiology, costs & burden of osteoporosis in 2011. Available at: https:\/\/www.iofbonehealth.org\/sites\/default\/files\/PDFs\/Audit%20Middle%20East_Africa\/Middle_East_Africa_audit.pdf. Acessed on: 01\/31\/2018"},{"key":"830_CR6","unstructured":"Kanis JA, on behalf of the World Health Organization Scientific Group (2007) Assessment of osteoporosis at the primary health-care level. Technical Report. World Health Organization Collaborating Centre for Metabolic Bone Diseases. UK, University of Sheffield"},{"issue":"7","key":"830_CR7","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1359\/JBMR.050304","volume":"20","author":"O Johnell","year":"2005","unstructured":"Johnell O, Kanis JA, Oden A, Johansson H, de Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D, Meunier PJ, Melton LJ III, O'Neill T, Pols H, Reeve J, Silman A, Tenenhouse A (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20(7):1185\u20131194","journal-title":"J Bone Miner Res"},{"key":"830_CR8","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism, Eighth edition","author":"ES Orwoll","year":"2013","unstructured":"Orwoll ES (2013) Osteoporosis in men. In: Rosen CJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, Eighth edition. Wiley-Blackwell John Wiley & Sons, Inc., Iowa"},{"key":"830_CR9","unstructured":"El-Badawy S, Abdel-Azeem H, El-Garf A et al (2012) Egyptian guidelines for the diagnosis and management of osteoporosis. ESOG, Cairo"},{"issue":"2","key":"830_CR10","first-page":"131","volume":"7","author":"G Maalouf","year":"2007","unstructured":"Maalouf G, Gannage-Yared MH, Ezzedine J et al (2007) Middle East and North Africa consensus on osteoporosis. J Musculoskelet Nueronal Interact 7(2):131\u2013143","journal-title":"J Musculoskelet Nueronal Interact"},{"issue":"1","key":"830_CR11","first-page":"37","volume":"28","author":"NA Jassim","year":"2017","unstructured":"Jassim NA, Adib G, Younis AAR et al (2017) Pan Arab osteoporosis society guidelines for osteoporosis management. Mediterr J Rheumatol 28(1):37\u201342","journal-title":"Mediterr J Rheumatol"},{"key":"830_CR12","unstructured":"Chakhtoura M, Baddoura R, Fuleihan GE et al (2013) Executive summary- Lebanese FRAX-based osteoporosis guidelines 2013. Available at: http:\/\/www.osteos.org.lb\/admin\/uploads\/Frax%20Leb%20OP%20Guidelines%202013%20-exec%20summ.pdf. Accessed on 5\/3\/2018"},{"issue":"6","key":"830_CR13","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2011-3045","volume":"97","author":"NB Watts","year":"2012","unstructured":"Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES, Finkelstein JS, Endocrine Society (2012) Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 97(6):1802\u20131822","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"830_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5144\/0256-4947.2015.1","volume":"35","author":"Y Al-Saleh","year":"2015","unstructured":"Al-Saleh Y, Sulimani R, Sabico S et al (2015) 2015 guidelines for osteoporosis in Saudi Arabia: recommendations from the Saudi osteoporosis society. Ann Saudi Med 35(1):1\u201312","journal-title":"Ann Saudi Med"},{"key":"#cr-split#-830_CR15.1","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN) (2015) Management of osteoporosis and the prevention of fragility fractures. Edinburgh: SIGN"},{"key":"#cr-split#-830_CR15.2","unstructured":"2015. (SIGN publication no. 142). [March 2015]. Available at: http:\/\/www.sign.ac.uk\/assets\/sign142.pdf. Accessed on 5\/3\/2018"},{"key":"830_CR16","unstructured":"IOF 2017 National & Regional Osteoporosis Guidelines Available at: https:\/\/www.iofbonehealth.org\/national-regional-osteoporosis-guidelines. Accessed on 5\/3\/2018"},{"key":"830_CR17","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","volume":"182","author":"M Brouwers","year":"2010","unstructured":"Brouwers M, Kho ME, Browman GP et al (2010) AGREE II: advancing guideline development, reporting and evaluation in healthcare. Can Med Assoc J 182:E839\u2013E842","journal-title":"Can Med Assoc J"},{"key":"830_CR18","unstructured":"Henein HW, Latif OT (2018) Master on therapeutic drugs. Nubar printing house. ISBN: 977-17-5538-2, Cairo"},{"key":"830_CR19","unstructured":"Health Insurance Organization (2017) Number of population and beneficiaries and coverage by governorate and sector. Available at: http:\/\/www.hio.gov.eg\/Ar\/covers\/Pages\/Chart1.aspx. Accessed on 5\/3\/2018"},{"issue":"17","key":"830_CR20","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1503\/cmaj.100771","volume":"182","author":"A Papaioannou","year":"2010","unstructured":"Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD, for the Scientific Advisory Council of Osteoporosis Canada (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. Can Med Assoc J 182(17):1864\u20131873","journal-title":"Can Med Assoc J"},{"key":"830_CR21","unstructured":"Joint Formulary Committee (2017) British National Formulary. March\u2013September 2017. BMJ group and pharmaceutical press, London"},{"issue":"6","key":"830_CR22","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1210\/jc.2011-3060","volume":"97","author":"MH Murad","year":"2012","unstructured":"Murad MH, Drake MT, Mullan RJ, Mauck KF, Stuart LM, Lane MA, Abu Elnour NO, Erwin PJ, Hazem A, Puhan MA, Li T, Montori VM (2012) Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis. J Clin Endocrinol Metab 97(6):1871\u20131880","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"830_CR23","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","volume":"280","author":"J Zhang","year":"1998","unstructured":"Zhang J, Yu KF (1998) What\u2019s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. J Am Med Assoc 280(19):1690\u20131691","journal-title":"J Am Med Assoc"},{"key":"830_CR24","unstructured":"National Institute for Health and Care Excellence (2014) Developing NICE guidelines: the manual. [London]: NICE. Available at: https:\/\/www.nice.org.uk\/guidance\/pmg20\/resources\/developing-nice-guidelines-the-manual-pdf-72286708700869. Accessed on 5\/3\/2018"},{"key":"830_CR25","unstructured":"Schunemann H, Brozek J, Guyatt G et al (2013) GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group, 2013. Available at: https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html. Accessed on 5\/3\/2018"},{"issue":"Supplement 2","key":"830_CR26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.rbr.2017.06.002","volume":"57","author":"MAR Loures","year":"2017","unstructured":"Loures MAR, Zerbini CA, Danowski JS et al (2017) Guidelines of the Brazilian Society of Rheumatology for the diagnosis and treatment of osteoporosis in men. Rev Bras Reumatol 57(Supplement 2):497\u2013514","journal-title":"Rev Bras Reumatol"},{"key":"830_CR27","first-page":"46","volume":"77","author":"L Schurman","year":"2017","unstructured":"Schurman L, Galich AM, Gonzalez C et al (2017) Gu\u00edas Argentinas para el diagn\u00f3stico, la prevenci\u00f3n y el tratamiento de la osteoporosis 2015. Medicina (Buenos Aires) 77:46\u201360","journal-title":"Medicina (Buenos Aires)"},{"key":"830_CR28","first-page":"3","volume":"35","author":"FE Abourazzak","year":"2016","unstructured":"Abourazzak FE, Khazzani H, Mansouri S et al (2016) Recommendations of the Moroccan Society of Rheumatology on vitamin D in adults. Revue Marocaine de Rhumatologie 35:3\u201315","journal-title":"Revue Marocaine de Rhumatologie"},{"issue":"9","key":"830_CR29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.rce.2015.08.003","volume":"215","author":"J Gonzalez-Macias","year":"2015","unstructured":"Gonzalez-Macias J, del Pino-Montes J, Olmos JM et al (2015) Clinical practice guidelines for posmenopausal, glucocorticoid-induced and male osteoporosis. Spanish Society for Research on Bone and Mineral Metabolism (3rd updated version 2014). Rev Clin Esp 215(9):515\u2013526","journal-title":"Rev Clin Esp"},{"key":"830_CR30","unstructured":"Rejnmark L, Abrahamsen B, Ejersted C et al (2012) Danish bone medical society; Vejledning til udredning og behandling af Osteoporose (2009; revised 2012). Available at: http:\/\/wp.dkms.dk\/wp-content\/uploads\/2013\/08\/Samlet-osteoporose_180913.pdf. Accessed on 5\/3\/2018"},{"key":"830_CR31","doi-asserted-by":"crossref","unstructured":"Shepherd JA, Schousboe JT, Broy SB, Engelke K, Leslie WD (2015) 2015 ISCD position development conference: executive summary of the 2015 ISCD position development conference on advanced measures from DXA and QCT: fracture prediction beyond BMD.\u00a0J Clin Densitom 18(3):274\u2013286","DOI":"10.1016\/j.jocd.2015.06.013"},{"issue":"1\u20132","key":"830_CR32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11657-012-0109-9","volume":"7","author":"H Orimo","year":"2012","unstructured":"Orimo H, Nakamura T, Hosoi T, Iki M, Uenishi K, Endo N, Ohta H, Shiraki M, Sugimoto T, Suzuki T, Soen S, Nishizawa Y, Hagino H, Fukunaga M, Fujiwara S (2012) Japanese 2011 guidelines for prevention and treatment of osteoporosis--executive summary. Arch Osteoporos 7(1\u20132):3\u201320","journal-title":"Arch Osteoporos"},{"key":"830_CR33","unstructured":"The Royal Australian College of General Practitioners and Osteoporosis Australia (2017) Osteoporosis prevention, diagnosis and management in postmenopausal women and men over 50 years of age (2nd edition). East Melbourne, Vic: RACGP"},{"issue":"5","key":"830_CR34","doi-asserted-by":"crossref","first-page":"604","DOI":"10.5603\/EP.2017.0062","volume":"68","author":"R Lorenc","year":"2017","unstructured":"Lorenc R, Gluszko P, Franek E et al (2017) Guidelines for the diagnosis and management of osteoporosis in Poland: update 2017. Endokrynol Pol 68(5):604\u2013609","journal-title":"Endokrynol Pol"},{"issue":"Supplement 1","key":"830_CR35","first-page":"180","volume":"22","author":"S Hough","year":"2017","unstructured":"Hough S, Amod A, Ascott-Evans BH et al (2017) South African clinical guideline for the diagnosis and management of osteoporosis: 2017. J Endocrinol Metab Diabetes S Afr 22(Supplement 1):180","journal-title":"J Endocrinol Metab Diabetes S Afr"},{"issue":"2","key":"830_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.afos.2016.02.004","volume":"2016","author":"SS Yeap","year":"2016","unstructured":"Yeap SS, Hew FL, Damodaran P et al (2016) A summary of the Malaysian clinical guidance on the management of postmenopausal and male osteoporosis, 2015. Osteoporos Sarcopenia 2016(2):1\u201312","journal-title":"Osteoporos Sarcopenia"},{"key":"830_CR37","unstructured":"JOPS (2016) The practical guide for management of osteoporosis. Available at: https:\/\/www.iofbonehealth.org\/sites\/default\/files\/media\/PDFs\/Jordanian%20Osteoporosis%20Prevention%20%20%20%20%20Society%20Guideline-2017.pdf. Accessed on 5\/3\/2018"},{"issue":"1","key":"830_CR38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00198-016-3766-5","volume":"28","author":"M Chakhtoura","year":"2017","unstructured":"Chakhtoura M, Leslie WD, McClung M, Cheung AM, Fuleihan GEH (2017) The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model. Osteoporos Int 28(1):127\u2013137","journal-title":"Osteoporos Int"},{"key":"830_CR39","unstructured":"Fuleihan GE, Baddoura R, Chakhtoura M et al (2014) 2014 FRAX based Lebanese osteoporosis guidelines. Available at: http:\/\/website.aub.edu.lb\/fm\/cmop\/downloads\/clinical-care-path.pdf. Accessed on 5\/3\/2018"},{"key":"830_CR40","unstructured":"ISCD (2015) 2015 ISCD official positions \u2013 adult Available at: https:\/\/www.iscd.org\/official-positions\/2015-iscd-official-positions-adult\/. Accessed on 5\/3\/2018"},{"issue":"3","key":"830_CR41","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jocd.2015.06.005","volume":"18","author":"SB Broy","year":"2015","unstructured":"Broy SB, Cauley JA, Lewiecki EM et al (2015) Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD official positions part 1: hip geometry. J Clin Densitom 18(3):287\u2013308. https:\/\/doi.org\/10.1016\/j.jocd.2015.06.005","journal-title":"J Clin Densitom"},{"issue":"3","key":"830_CR42","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jocd.2015.06.008","volume":"18","author":"BC Silva","year":"2015","unstructured":"Silva BC, Broy SB, Boutroy S, Schousboe JT, Shepherd JA, Leslie WD (2015) Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD official positions part 2: trabecular bone score. J Clin Densitom 18(3):309\u2013330. https:\/\/doi.org\/10.1016\/j.jocd.2015.06.008","journal-title":"J Clin Densitom"},{"issue":"3","key":"830_CR43","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jocd.2015.06.006","volume":"18","author":"TJ Beck","year":"2015","unstructured":"Beck TJ, Broy SB (2015) Measurement of hip geometry\u2014technical background. J Clin Densitom 18(3):331\u2013337. https:\/\/doi.org\/10.1016\/j.jocd.2015.06.006","journal-title":"J Clin Densitom"},{"issue":"3","key":"830_CR44","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jocd.2015.06.012","volume":"18","author":"K Engelke","year":"2015","unstructured":"Engelke K, Lang T, Khosla S, Qin L, Zysset P, Leslie WD, Shepherd JA, Schousboe JT (2015) Clinical use of quantitative computed tomography (QCT) of the hip in the management of osteoporosis in adults: the 2015 ISCD official positions\u2014part I. J Clin Densitom 18(3):338\u2013358. https:\/\/doi.org\/10.1016\/j.jocd.2015.06.012","journal-title":"J Clin Densitom"},{"issue":"3","key":"830_CR45","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jocd.2015.06.011","volume":"18","author":"P Zysset","year":"2015","unstructured":"Zysset P, Qin L, Lang T, Khosla S, Leslie WD, Shepherd JA, Schousboe JT, Engelke K (2015) Clinical use of quantitative computed tomography\u2013based finite element analysis of the hip and spine in the management of osteoporosis in adults: the 2015 ISCD official positions\u2014part II. J Clin Densitom 18(3):359\u2013392. https:\/\/doi.org\/10.1016\/j.jocd.2015.06.011","journal-title":"J Clin Densitom"},{"issue":"3","key":"830_CR46","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jocd.2015.06.010","volume":"18","author":"K Engelke","year":"2015","unstructured":"Engelke K, Lang T, Khosla S, Qin L, Zysset P, Leslie WD, Shepherd JA, Shousboe JT (2015) Clinical use of quantitative computed tomography\u2013based advanced techniques in the management of osteoporosis in adults: the 2015 ISCD official positions\u2014part III. J Clin Densitom 18(3):393\u2013407. https:\/\/doi.org\/10.1016\/j.jocd.2015.06.010","journal-title":"J Clin Densitom"},{"issue":"9","key":"830_CR47","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00198-012-1958-1","volume":"23","author":"S Lekamwasam","year":"2012","unstructured":"Lekamwasam S, Adachi JD, Agnusdei D et al (2012) A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int 23(9):2257\u20132276","journal-title":"Osteoporos Int"},{"issue":"1\u20132","key":"830_CR48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11657-012-0070-7","volume":"7","author":"S Lekamwasam","year":"2012","unstructured":"Lekamwasam S, Adachi JD, Agnusdei D et al (2012) An appendix to the 2012 IOF\u2013ECTS guidelines for the management of glucocorticoid-induced osteoporosis. Arch Osteoporos 7(1\u20132):25\u201330","journal-title":"Arch Osteoporos"},{"issue":"6","key":"830_CR49","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1210\/jc.2011-3058","volume":"97","author":"MT Drake","year":"2012","unstructured":"Drake MT, Murad MH, Mauck KF, Lane MA, Undavalli C, Elraiyah T, Stuart LM, Prasad C, Shahrour A, Mullan RJ, Hazem A, Erwin PJ, Montori VM (2012) Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. J Clin Endocrinol Metab 97(6):1861\u20131870","journal-title":"J Clin Endocrinol Metab"},{"key":"830_CR50","unstructured":"Hamdy G, Hassouna A, Nassar H et al (2015) Cost-effectiveness of zoledronic acid as versus pamidronic acid in the treatment of breast cancer patients with bone metastasis: a decision tree model. Available at: http:\/\/www.eda.mohp.gov.eg\/Files\/1049_Zoledronic_acid_TA_report.pdf. Accessed on 5\/3\/2018"},{"key":"830_CR51","unstructured":"Hamdy G, El-dessouki R, Hassouna A et al (2016) Cost-effectiveness of denosumab versus zoledronic acid in the treatment of breast and prostate cancer patients with bone metastasis: a decision tree model. Available at: http:\/\/www.eda.mohp.gov.eg\/Files\/1046_Denosumab_TA_report.pdf. Accessed on 5\/3\/2018"},{"key":"830_CR52","unstructured":"Hamdy G, Hassouna A, Nassar H et al (2016) Cost-effectiveness analysis of teriparatide versus alendronic acid in the treatment of osteoporosis in postmenopausal Egyptian patients: health technology appraisal. Available at: http:\/\/www.eda.mohp.gov.eg\/Files\/1031_Teriparatide_TA_report.pdf. Accessed on 5\/3\/2018"},{"key":"830_CR53","unstructured":"Hassouna A, Nabhan A, Nassar H et al (2014) Cost-effectiveness of zoledronic acid versus alendronic acid in the treatment of osteoporosis in postmenopausal Egyptian patients: a Markov model. Available at: http:\/\/www.eda.mohp.gov.eg\/Files\/833_12_Zoledronic_Acid_TA_report.pdf. Accessed on 5\/3\/2018"},{"key":"830_CR54","unstructured":"Reid DM, Stewart A, NOS Bone Densitometry Forum Committee (2001) Position statement on the use of quantitative ultrasound in the management of osteoporosis. National Osteoporosis Society. Available at: https:\/\/nos.org.uk\/media\/2071\/qus-in-the-management-of-osteoporosis.pdf. Accessed on: 7\/6\/2018"},{"key":"830_CR55","unstructured":"WHO 2016 Global Health Observatory (GHO) data: Life expectancy Available at: http:\/\/www.who.int\/gho\/mortality_burden_disease\/life_tables\/situation_trends\/en\/. Accessed on 5\/3\/2018"},{"issue":"3","key":"830_CR56","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jocd.2011.05.015","volume":"14","author":"JA Cauley","year":"2011","unstructured":"Cauley JA, Fuleihan GA, Arabi A et al (2011) Official positions for FRAX clinical regarding international differences. J Clin Densitom 14(3):240\u2013262","journal-title":"J Clin Densitom"},{"issue":"1","key":"830_CR57","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11657-016-0278-z","volume":"11","author":"JA Kanis","year":"2016","unstructured":"Kanis JA, Harvey NC, Cooper C et al (2016) A systematic review of intervention thresholds based on FRAX : a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11(1):25","journal-title":"Arch Osteoporos"},{"issue":"7","key":"830_CR58","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari AH et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911\u20131930","journal-title":"J Clin Endocrinol Metab"},{"key":"830_CR59","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/9781118453926.ch45","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism, Eighth edition","author":"HA Bischoff-Ferrari","year":"2013","unstructured":"Bischoff-Ferrari HA (2013) Prevention of falls. In: Rosen CJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, Eighth edition. Wiley-Blackwell John Wiley & Sons, Inc., Iowa, pp 389\u2013395"},{"key":"830_CR60","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/9781118453926.ch47","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism, Eighth edition","author":"B Dawson-Hughes","year":"2013","unstructured":"Dawson-Hughes B (2013) Calcium and vitamin D. In: Rosen CJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, Eighth edition. Wiley-Blackwell John Wiley & Sons, Inc., Iowa, pp 403\u2013407"},{"key":"830_CR61","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/9781118453926.ch46","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism, Eighth edition","author":"CT Rubin","year":"2013","unstructured":"Rubin CT, Rubin J, Judex S (2013) Exercise and the prevention of osteoporosis. In: Rosen CJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, Eighth edition. Wiley-Blackwell John Wiley & Sons, Inc., Iowa, pp 396\u2013402"},{"key":"830_CR62","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/9781118453926.ch42","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism, Eighth edition","author":"CM Weaver","year":"2013","unstructured":"Weaver CM, Heaney RP (2013) Nutrition and osteoporosis. In: Rosen CJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, Eighth edition. Wiley-Blackwell John Wiley & Sons, Inc., Iowa, pp 361\u2013366"},{"key":"830_CR63","first-page":"297","volume-title":"ACSM's guidelines for exercise testing and prescription (10th ed.)","author":"American College Of Sports Medicine","year":"2017","unstructured":"American College Of Sports Medicine (2017) Ch11: exercise testing and prescription for populations with other chronic diseases and health conditions. In: ACSM's guidelines for exercise testing and prescription (10th ed.). Wolters Kluwer, Philadelphia, pp 297\u2013376"},{"issue":"3","key":"830_CR64","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00198-017-3906-6","volume":"28","author":"A Diez-Perez","year":"2017","unstructured":"Diez-Perez A, Naylor KE, Abrahamsen B et al (2017) International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates. Osteoporos Int 28(3):767\u2013774","journal-title":"Osteoporos Int"},{"key":"830_CR65","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cca.2016.06.036","volume":"467","author":"HA Morris","year":"2017","unstructured":"Morris HA, Eastell R, Jorgensen NR, Cavalier E, Vasikaran S, Chubb SAP, Kanis JA, Cooper C, Makris K (2017) Clinical usefulness of bone turnover marker concentrations in osteoporosis. Clin Chim Acta 467:34\u201341","journal-title":"Clin Chim Acta"},{"issue":"1","key":"830_CR66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"AA Khan","year":"2015","unstructured":"Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O'Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, al Dabagh R, Davison KS, Kendler DL, S\u00e1ndor GK, Josse RG, Bhandari M, el Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J, on behalf of the International Task Force on Osteonecrosis of the Jaw (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30(1):3\u201323","journal-title":"J Bone Miner Res"},{"issue":"8","key":"830_CR67","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.40137","volume":"69","author":"L Buckey","year":"2017","unstructured":"Buckey L, Guyatt G, Fink HA et al (2017) 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 69(8):1521\u20131537","journal-title":"Arthritis Rheum"},{"key":"830_CR68","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/9781118453926.ch55","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism, Eighth edition","author":"ANA Tosteson","year":"2013","unstructured":"Tosteson ANA (2013) Cost-effectiveness of osteoporosis treatment. In: Rosen CJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, Eighth edition. Wiley-Blackwell John Wiley & Sons, Inc., Iowa, pp 455\u2013468"},{"key":"830_CR69","unstructured":"National Institute for Health and Care Excellence (2012) Osteoporosis: assessing the risk of fragility fracture. Available at: https:\/\/www.nice.org.uk\/Guidance\/cg146. Accessed on 5\/3\/2018"},{"key":"830_CR70","unstructured":"El-Masry SA, Hassan NE, El-Banna RA (2015) A new predictive index for osteoporosis among a sample of postmenopausal Egyptian women. Res J Pharm Biol Chem Sci 6(1):975\u2013981"},{"issue":"1","key":"830_CR71","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11657-017-0332-5","volume":"12","author":"A Satyaraddi","year":"2017","unstructured":"Satyaraddi A, Shetty S, Kapoor N, Cherian KE, Naik D, Thomas N, Paul TV (2017) Performance of risk assessment tools for predicting osteoporosis in south Indian rural elderly men. Arch Osteoporos 12(1):35\u201339","journal-title":"Arch Osteoporos"},{"issue":"4","key":"830_CR72","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3122\/jabfm.2013.04.120182","volume":"26","author":"AR Cass","year":"2013","unstructured":"Cass AR, Shepherd AJ (2013) Validation of the male osteoporosis risk estimation score (MORES) in a primary care setting. JABFM 26(4):436\u2013444","journal-title":"JABFM"},{"key":"830_CR73","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11657-016-0298-8","volume":"12","author":"A Kharroubi","year":"2017","unstructured":"Kharroubi A, Saba E, Ghannam I, Darwish H (2017) Evaluation of the validity of osteoporosis and fracture risk assessment tools (IOF one minute test, SCORE, and FRAX) in postmenopausal Palestinian women. Arch Osteoporos 12:6. https:\/\/doi.org\/10.1007\/s11657-016-0298-8","journal-title":"Arch Osteoporos"},{"key":"830_CR74","unstructured":"IOF (2017) Arabic IOF one-minute osteoporosis risk test: 19 easy questions to help you understand the status of your bone health. Available at: https:\/\/www.iofbonehealth.org\/sites\/default\/files\/media\/arabic%20_oneminuterisktest_NewLayout_14082017.pdf. Accessed on 5\/3\/2018"},{"key":"830_CR75","unstructured":"Association TTO (2013) Taiwanese guidelines for prevention and treatment of osteoporosis. Available at: https:\/\/www.iofbonehealth.org\/sites\/default\/files\/PDFs\/National%20Guidelines\/Taiwanese_guidelines_prevention_treatment_osteoporosis.pdf. Accessed on 5\/3\/2018"},{"issue":"7","key":"830_CR76","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/jbmr.5650110716","volume":"11","author":"HK Genant","year":"1996","unstructured":"Genant HK, Jerqas M, Palermo L et al (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. J Bone Miner Res 11(7):984\u2013996","journal-title":"J Bone Miner Res"},{"issue":"1","key":"830_CR77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4081\/reumatismo.2016.870","volume":"68","author":"M Rossini","year":"2016","unstructured":"Rossini M, Adami S, Bertoldo F, Diacinti D, Gatti D, Giannini S, Giusti A, Malavolta N, Minisola S, Osella G, Pedrazzoni M, Sinigaglia L, Viapiana O, Isaia GC (2016) Guidelines for the diagnosis, prevention and management of osteoporosis. Reumatismo 68(1):1\u201339","journal-title":"Reumatismo"},{"issue":"6","key":"830_CR78","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","volume":"95","author":"S Bhasin","year":"2010","unstructured":"Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM (2010) Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95(6):2536\u20132559","journal-title":"J Clin Endocrinol Metab"},{"key":"830_CR79","unstructured":"National Institute for Health and Care Excellence (2008) Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. Available at: https:\/\/www.nice.org.uk\/guidance\/ta161\/resources\/raloxifene-and-teriparatide-for-the-secondary-prevention-of-osteoporotic-fragility-fractures-in-postmenopausal-women-pdf-82598370170821. Accessed on 5\/3\/2018"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-020-00830-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-020-00830-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-020-00830-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T07:30:24Z","timestamp":1633851024000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-020-00830-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["830"],"URL":"https:\/\/doi.org\/10.1007\/s11657-020-00830-4","relation":{},"ISSN":["1862-3522","1862-3514"],"issn-type":[{"type":"print","value":"1862-3522"},{"type":"electronic","value":"1862-3514"}],"subject":[],"published":{"date-parts":[[2020,10,9]]},"assertion":[{"value":"19 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}],"article-number":"159"}}